Flotek Industries Inc
FTK- Exchange
- NYSE
- Industry
- Miscellaneous Chemical Products
- SEC CIK
- 0000928054
In the last 90 days, Flotek Industries Inc insiders filed 1 open-market purchase and 2 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $288.8M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:36 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 11, 2026 | Jan 30, 2025 | Mar 12, 2024 | Mar 21, 2023 | Mar 31, 2022 |
| Revenue | $237.3M | $187.0M | $188.1M | $136.1M | $43.3M |
| Cost of revenue | $177.4M | $147.6M | $163.8M | $142.8M | $40.0M |
| Gross profit | $59.8M | $39.4M | $24.3M | -$6.70M | $3.26M |
| Research and development | $1.82M | $1.71M | $2.49M | $4.44M | $5.54M |
| Selling, general and administrative | $28.0M | $24.7M | $27.9M | $27.1M | $20.2M |
| Operating income | $23.2M | $12.2M | $23.2M | -$35.4M | -$31.5M |
| Interest expense | – | – | $2.86M | $7.05M | $78.0K |
| Income tax | -$10.9M | $649.0K | $149.0K | -$22.0K | -$40.0K |
| Net income | $30.5M | $10.5M | $24.7M | -$42.3M | -$30.5M |
| EPS, basic | $0.90 | $0.36 | $1.00 | $-0.57 | $-0.42 |
| EPS, diluted | $0.84 | $0.34 | $-0.10 | $-0.57 | $-0.42 |
| Weighted shares, basic | 33.9M | 29.5M | 24.8M | 74.4M | 73.4M |
| Weighted shares, diluted | 36.2M | 30.9M | 28.4M | 74.4M | 73.4M |
| Margins and growth | |||||
| Gross margin | 25.2% | 21.1% | 12.9% | -4.9% | 7.5% |
| Operating margin | 9.8% | 6.5% | 12.3% | -26.0% | -72.7% |
| Net margin | 12.9% | 5.6% | 13.1% | -31.1% | -70.6% |
| Revenue growth, year over year | +26.9% | −0.5% | +38.2% | +214.5% | −18.6% |
| Net income growth, year over year | +190.8% | −57.5% | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 11, 2026 | Jan 30, 2025 | Mar 12, 2024 | Mar 21, 2023 | Mar 31, 2022 |
| Cash and equivalents | $5.73M | $4.40M | $5.85M | $12.3M | $11.5M |
| Accounts receivable | – | – | – | $19.1M | $13.3M |
| Inventory | $10.6M | $13.3M | $12.8M | $15.7M | $9.45M |
| Total current assets | $110.8M | $96.5M | $76.4M | $81.1M | $42.6M |
| Goodwill | – | – | – | – | $0 |
| Total assets | $220.0M | $170.8M | $157.5M | $164.8M | $50.2M |
| Accounts payable | $48.3M | $38.1M | $31.7M | $33.4M | $7.62M |
| Short-term debt | – | – | – | – | $1.44M |
| Total current liabilities | $61.6M | $50.4M | $47.8M | $151.4M | $18.8M |
| Long-term debt | $40.0M | $0 | $60.0K | $2.74M | $3.35M |
| Total liabilities | $107.0M | $56.9M | $55.6M | $162.2M | $30.1M |
| Shareholders' equity | $113.1M | $113.9M | $102.0M | $2.60M | $20.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 11, 2026 | Jan 30, 2025 | Mar 12, 2024 | Mar 21, 2023 | Mar 31, 2022 |
| Operating cash flow | $7.20M | $3.36M | -$11.3M | -$44.6M | -$25.8M |
| Capital expenditures | – | – | – | $421.0K | $39.0K |
| Free cash flow | – | – | – | -$45.1M | -$25.9M |
| Depreciation and amortization | – | – | – | – | $1.01M |
| Stock-based compensation | $2.30M | $1.37M | -$254.0K | $3.33M | $3.76M |
| Investing cash flow | -$1.98M | -$1.82M | -$1.01M | $5.33M | $112.0K |
| Financing cash flow | -$3.74M | -$3.12M | $5.93M | $38.3M | -$372.0K |
| Net change in cash | $1.33M | -$1.45M | -$6.44M | -$934.0K | -$26.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.0% | 0.7% | -0.1% | 2.4% | 8.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 36.3M | +20.7% | SEC |
| Aug 3, 2026 | 36.2M | +21.3% | SEC |
| May 4, 2026 | 36.2M | +21.3% | SEC |
| Mar 13, 2026 | 36.2M | +21.3% | SEC |
| Nov 3, 2025 | 30.1M | +0.9% | SEC |
| Aug 5, 2025 | 29.9M | +0.2% | SEC |
| May 5, 2025 | 29.8M | +0.6% | SEC |
| Mar 10, 2025 | 29.8M | +0.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Dec 31, 2020, from 13F share counts: 1-for-6 in Q3 2023.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.